Begemann, M. (Contributor), Thompson, I. (Contributor), Veling, W. (Contributor), Gangadin, S. (Contributor), Geraets, C. (Contributor), Hag, E. V. ‘. (Contributor), Müller-Kuperus, S. (Contributor), Oomen, P. (Contributor), Voppel, A. (Contributor), Gaag, M. (Contributor), Kikkert, M. (Contributor), Os, J. (Contributor), Smit, H. (Contributor), Knegtering, R. (Contributor), Wiersma, S. (Contributor), Stouten, L. (Contributor), Gijsman, H. (Contributor), Wunderink, L. (Contributor), Staring, A. (Contributor), Veerman, S. (Contributor), Mahabir, A. (Contributor), Kurkamp, J. (Contributor), Pijnenborg, G. (Contributor), Veen, N. (Contributor), Marcelis, M. (Contributor), Grootens, K. (Contributor), Faber, G. (Contributor), Beveren, N. (Contributor), Been, A. (Contributor), Brink, T. (Contributor), Bak, M. (Contributor), Amelsvoort, T. (Contributor), Ruissen, A. (Contributor), Blanke, C. (Contributor), Groen, K. (Contributor), Haan, L. (Contributor), Sommer, I. (Contributor) (
7 Feb 2020). Additional file 1 of To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. Unknown Publisher.
10.6084/m9.figshare.11826258.v1